Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer.
Year: 1998
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Authors: B D Curti, A C Ochoa, G C Powers, W C Kopp, W G Alvord, J E Janik, B L Gause, B Dunn, M S Kopreski, R Fenton, A Zea, C Dansky-Ullmann, S Strobl, L Harvey, E Nelson, M Sznol, D L Longo
Institution: National Cancer Institute
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2275107161